Show simple item record

Files in this item

Thumbnail

Item metadata

dc.contributor.authorEllington, M.J.
dc.contributor.authorReuter, S.
dc.contributor.authorHarris, S.R.
dc.contributor.authorHolden, M.T.G.
dc.contributor.authorCartwright, E.J.
dc.contributor.authorGreaves, D.
dc.contributor.authorGerver, S.M.
dc.contributor.authorHope, R.
dc.contributor.authorBrown, N.M.
dc.contributor.authorTörök, M.E.
dc.contributor.authorParkhill, J.
dc.contributor.authorKöser, C.U.
dc.contributor.authorPeacock, S.J.
dc.date.accessioned2015-03-26T13:01:06Z
dc.date.available2015-03-26T13:01:06Z
dc.date.issued2015-05
dc.identifier.citationEllington , M J , Reuter , S , Harris , S R , Holden , M T G , Cartwright , E J , Greaves , D , Gerver , S M , Hope , R , Brown , N M , Török , M E , Parkhill , J , Köser , C U & Peacock , S J 2015 , ' Emergent and evolving antimicrobial resistance cassettes in community-associated fusidic acid and meticillin-resistant Staphylococcus aureus ' , International Journal of Antimicrobial Agents , vol. 45 , no. 5 , pp. 477-484 . https://doi.org/10.1016/j.ijantimicag.2015.01.009en
dc.identifier.issn0924-8579
dc.identifier.otherPURE: 176930846
dc.identifier.otherPURE UUID: 84e1bba6-ce7e-460a-8c28-97511edf82fe
dc.identifier.otherScopus: 84939983385
dc.identifier.otherORCID: /0000-0002-4958-2166/work/60196472
dc.identifier.urihttp://hdl.handle.net/10023/6349
dc.descriptionThis study was supported by grants from the UKCRC Translational Infection Research Initiative and the Medical Research Council [grant no. G1000803] with contributions to the grant from the Biotechnology and Biological Sciences Research Council, the National Institute for Health Research on behalf of the Department of Health, and the Chief Scientist Office of the Scottish Government Health Directorate (to Prof. Peacock); by the Wellcome Trust [grant no. 098051 awarded to the Wellcome Trust Sanger Institute]; by the Health Protection Agency (to Prof. Peacock); and by the NIHR Cambridge Biomedical Research Centre (to Dr Török and Prof. Peacock). EMT is a Clinician Scientist Fellow funded by the Academy of Medical Sciences and the Health Foundation.en
dc.description.abstractFusidic acid is a topical and systemic antimicrobial used for the treatment of staphylococcal infections in hospitals and the community. Sales of fusidic acid and resistance rates among meticillin-resistant Staphylococcus aureus (MRSA) doubled between 1990 and 2001. For the following decade, fusidic acid resistance rates among isolates from Addenbrooke's Hospital (Cambridge, UK) were compared with national resistance rates from MRSA bacteraemia surveillance data and with antimicrobial sales data. Sales of fusidic acid remained relatively constant between 2002 and 2012, whilst fusidic acid resistance increased two- and four-fold in MRSA bacteraemias nationally and in MRSA isolates from Cambridge, respectively. A subgroup of MRSA resistant only to fusidic acid increased after 2006 by 5-fold amongst bacteraemias nationally and 17-fold (to 7.7% in 2012) amongst Cambridge MRSA isolates. All of the available local isolates from 2011 to 2012 (n = 23) were acquired in the community, were not related epidemiologically and belonged to multilocus sequence typing (MLST) groups ST1, 5, 8, 45 or 149 as revealed from analysis of whole-genome sequence data. All harboured the fusC gene on one of six distinct staphylococcal cassette chromosome (SCC) elements, four of which were dual-resistance chimeras that encoded β-lactam and fusidic acid resistance. In summary, fusidic acid-resistant MRSA increased in prevalence during the 2000s with notable rises after 2006. The development of chimeric cassettes that confer dual resistance to β-lactams and fusidic acid demonstrates that the genetics underpinning resistance in community-associated MRSA are evolving.
dc.language.isoeng
dc.relation.ispartofInternational Journal of Antimicrobial Agentsen
dc.rights© 2015 The Authors. Published by Elsevier B.V. on behalf of International Society of Chemotherapy. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).en
dc.subjectCA-MRSAen
dc.subjectAntimicrobial resistanceen
dc.subjectSurveillanceen
dc.subjectSCC genomicsen
dc.subjectQR Microbiologyen
dc.subjectQR180 Immunologyen
dc.subjectR Medicine (General)en
dc.subjectDASen
dc.subject.lccQRen
dc.subject.lccQR180en
dc.subject.lccR1en
dc.titleEmergent and evolving antimicrobial resistance cassettes in community-associated fusidic acid and meticillin-resistant Staphylococcus aureusen
dc.typeJournal articleen
dc.description.versionPublisher PDFen
dc.contributor.institutionUniversity of St Andrews.School of Medicineen
dc.contributor.institutionUniversity of St Andrews.Infection Groupen
dc.contributor.institutionUniversity of St Andrews.Biomedical Sciences Research Complexen
dc.identifier.doihttps://doi.org/10.1016/j.ijantimicag.2015.01.009
dc.description.statusPeer revieweden
dc.identifier.urlhttp://www.sciencedirect.com/science/article/pii/S0924857915000643#appd002en


This item appears in the following Collection(s)

Show simple item record